TY - JOUR
T1 - Management of individual tumor syndromes
T2 - Pituitary neoplasia
AU - McCutcheon, I. E.
PY - 1994
Y1 - 1994
N2 - The majority of pituitary adenomas associated with MEN 1 secrete prolactin or growth hormone. For both types, medical treatment is an acceptable option, particularly for prolactinomas. A significant number of patients with this syndrome will, however, require surgery because of ineffectiveness of medical therapy or compression or invasion of parasellar structures. This article discusses current strategies for the medical and surgical management of prolactinomas and of acromegaly, with special attention to the diagnostic and therapeutic pitfalls associated with MEN 1.
AB - The majority of pituitary adenomas associated with MEN 1 secrete prolactin or growth hormone. For both types, medical treatment is an acceptable option, particularly for prolactinomas. A significant number of patients with this syndrome will, however, require surgery because of ineffectiveness of medical therapy or compression or invasion of parasellar structures. This article discusses current strategies for the medical and surgical management of prolactinomas and of acromegaly, with special attention to the diagnostic and therapeutic pitfalls associated with MEN 1.
UR - http://www.scopus.com/inward/record.url?scp=0028213296&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028213296&partnerID=8YFLogxK
U2 - 10.1016/s0889-8529(18)30114-2
DO - 10.1016/s0889-8529(18)30114-2
M3 - Review article
C2 - 7913028
AN - SCOPUS:0028213296
SN - 0889-8529
VL - 23
SP - 37
EP - 51
JO - Endocrinology and Metabolism Clinics of North America
JF - Endocrinology and Metabolism Clinics of North America
IS - 1
ER -